Global squamous cell carcinoma of the head and neck treatment market size to reach US$ 1.9 Bn by 2026 at a CAGR of 9.4%

Noida, Uttar Pradesh, India, March 23 2021 (Wiredrelease) Report Ocean Pvt Ltd –:Cancers of the head and neck are among the most prevailing cancers due to the association with the human papillomavirus (HPV) infection, making up 50,000 new cases a year in the US. Squamous cell carcinoma of the head and neck occurs most often in men aged above 50 years. However, its incidence is increasing among younger individuals. Squamous cell carcinoma makes up around 90.0% of these types of cancers. The first-line treatment for squamous cell carcinoma of the head and neck is typically TransOral Robotic Surgery (TORS), a minimally invasive surgical procedure. The advantage of surgery is to reduce the dose and simultaneously eliminate the need for radiation therapy to treat cancer.

GET SAMPLE PAGES @ https://www.reportocean.com/industry-verticals/sample-request?report_id=QY6780

Bristol-Myers Squibb’s Opdivo and Merck & Co.’s Keytruda are already deep-rooted and efficient therapeutic options for previously treated recurrent or metastatic squamous cell carcinoma of the head and neck. In 2019, Merck & Co. expanded its label of Keytruda by revolutionizing the choice of first-line therapy for squamous cell carcinoma of the head and neck by offering relatively better targeted therapeutic options with Keytruda treatments based on characteristics of patients, such as PD-L1 expression. This is expected to shift current treatment practices to this advanced treatment procedure in the near future. Following these promising developments, the Global Squamous Cell Carcinoma of the Head and Neck Treatment Market is estimated to see considerable growth, pegged at a CAGR of around 9.2% throughout the forecast period (2020-2025).

Impact of COVID-19 on Squamous Cell Carcinoma of the Head and Neck Treatment and Drugs

Several drugs that the FDA approves are currently under clinical trials, and the pharmaceutical companies are continuously focusing on the R&D of these drugs. However, the COVID-19 pandemic has hampered the clinical trials of the drugs, as government and private entities have shifted their attention towards the development of the COVID-19 vaccine, which in turn, has impacted the study of organizations focusing on the development of the drugs for squamous cell carcinoma of the head and neck. Moreover, the hospitals observed a lower number of cancer patients due to the fear of spreading the COVID-19, which impacted the study of the clinical trials for the cancer vaccine.

Segmentation Overview of the Global Squamous Cell Carcinoma of the Head and Neck Treatment Market

The squamous cell carcinoma of the head and neck treatment market is segmented on type, diagnosis, treatment, therapeutic class, and end user. These major market segments are further categorized into various sub-segments to study the market in detail.

By Type (Salivary Gland, Nasal Cavity & Paranasal Sinus, Oral & Oropharyngeal, Nasopharyngeal, Laryngeal & Hypo Pharyngeal)

By Diagnosis (Bioscopy Screening Tests, Imaging, Blood Tests, Dental Diagnosis, Endoscopy)

By Treatment (Radiation, Surgery, Chemotherapy, Immunotherapy)

By Therapeutic Class (PD Inhibitors, EGFR Inhibitors, Microtubule Inhibitors, Mitotic Inhibitors)

By End User (Hospitals & Clinics, Ambulatory Surgical Centers)

Key Players Insights

Sanofi SA, Pfizer Inc., Bristol-Myers Squibb Company, Merck KGaA, Eli Lilly and Company, Bayer AG, Fresenius Kabi AG, AB SCIENCE, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Acceleron Pharma Inc., Astellas Pharma Inc., AstraZeneca PLC, among others, are some significant players included in the research study of the global squamous cell carcinoma of the head and neck treatment market.

Feel Free To Ask Question Before Purchasing The Report @ https://www.reportocean.com/industry-verticals/sample-request?report_id=QY6780

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is “one-stop solution” for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:

Nishi Sharma

Email: sales@reportocean.com

Address: 500 N Michigan Ave, Suite 600, Chicago, IIIinois 60611 – UNITED STATES

Tel: +1 888 212 3539 (US – TOLL FREE)

Website: https://www.reportocean.com/

This content has been published by Report Ocean Pvt Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at contact@wiredrelease.com.